Merck Settles Anti-Kickback and Drug Rebate Allegations with Federal and State Governments

Merck agreed to settle two whistleblower lawsuits under the False Claims Act that alleged best price reporting violations and illegal kickbacks to doctors and hospitals. With interest included, the total settlement amount of the lawsuits was $671 million. In addition, Merck agreed to enter into a Corporate Integrity Agreement with the Office of Inspector General (“OIG”).


Click the link below to read the full alert.